<DOC>
	<DOCNO>NCT01787240</DOCNO>
	<brief_summary>We research study find people get well take specific kind antidepressant medication ( selective serotonin reuptake inhibitor , SSRI ) people get well take placebo ( inactive substance ) similar chemical brain . Some participant may complete procedure call Acute Tryptophan Depletion ( ATD ) , way study role serotonin depression . Some participant may also undergo magnetic resonance-positron emission tomography ( MR-PET ) scan .</brief_summary>
	<brief_title>Neurobiological Bases Placebo Response Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Meets diagnostic criterion Major Depressive Disorder Written inform consent Men woman age 1860 year old A score 18 great HAMD28 Patient must continue meet criterion current MDD baseline . Patients must Clinical Global Impression Improvement ( CGI ) score â‰¥ 3 ( i.e . minimally improve less ) screen baseline visit Agreeing , eligible procedure ( patient 1845 eligible MRPET study ) Pregnant woman woman child bear potential use medically accept mean contraception Patients serious suicide homicide risk Unstable medical illness include cardiovascular , hepatic , renal , respiratory , endocrine , neurological , hematological disease , uncontrolled seizure disorder The following DSMIV diagnosis : ) organic mental disorder b ) substance use disorder , include alcohol , active within last year ; c ) schizophrenia ; ) delusional disorder ; e ) psychotic disorder elsewhere classify ; f ) bipolar disorder ; g ) acute bereavement ; h ) borderline antisocial personality disorder ) current primary diagnosis panic disorder , social phobia , GAD , OCD ( disorder present chief complaint and/or onset precede onset MDD ) , l ) Patients mood congruent mood incongruent psychotic feature Currently take follow exclusionary medication : antipsychotic , anticonvulsant , mood stabilizer , stimulant , antidepressant , potential antidepressant augment agent ( e.g. , T3 , SAMe , St. John 's Wort , lithium , buspirone , Omega 3 fatty acid ) . If determine safe discontinue medication , patient require wait period equivalent least 5 half life drug screen Patients take investigational psychotropic drug within last year Patients respond one antidepressant trial adequate dos ( e.g. , fluoxetine 40 mg/day high ) duration ( e.g. , six week ) past five year , define MGHATRQ History inadequate response poor tolerability citalopram escitalopram Any concomitant form psychotherapy ( depressionfocused ) Receiving receive index episode Vagal nerve stimulation , ECT rTMS , somatic antidepressant treatment Any reason list , determine site PI study clinician , constitute good clinical practice make participation study hazardous Contraindications fMRI scan MRPET scanning ( include presence cardiac pacemaker pacemaker wire , metallic particle body , vascular clip head previous neurosurgery , prosthetic heart valve , claustrophobia ) MRPETspecific exclusion criterion : Patients young 18 old 45 year age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>